20 results
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
, making it obsolete or noncompetitive before we recover the expense of developing and commercializing. Our competitors could also recruit our
PRE 14A
wx4sm0
14 Apr 23
Preliminary proxy
4:11pm
10-K
zk9crx45akfymy twj0b
29 Mar 22
Annual report
5:09pm
424B4
le4ei3is 8dgu
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
3hzlnpdm7y2lhgjcy7
25 Aug 21
Draft registration statement
12:00am
10-Q
018rlzpgr 20hk
7 Jun 21
Quarterly report
7:17am
424B1
qns3wevivub6ivqochcb
23 Apr 21
Prospectus with pricing info
4:01pm
S-1
eexqw iyq7na3t
2 Apr 21
IPO registration
3:04pm
DRS/A
ni50q8lvbs gmo9
23 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next